Latest Episodes
25
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to...
24
Episode 24: Gadi Lachman, President and CEO, TriNetX
Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien,...
23
Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India
What makes India a smart and viable setting for today’s clinical trials? Join us for the latest episode of Few & Far Between. Biorasi's ...
22
Episode 22: Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics, Host of Lady Scientist Podcast
How can DAOs - Decentralized Autonomous Organizations - improve rare disease research? Biorasi's Few & Far Between Podcast welcomes Dr. Jocelynn Pearl, Senior Scientist...
21
Episode 21: Jill Hawkins, Founder and President of the FAM177A1 Research Fund
How do you start in building a rare disease foundation? Biorasi's Few & Far Between Podcast Welcomes Jill Hawkins, Founder and President of the...
20
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.
What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E....